💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
User | Tweets |
---|---|
@newsfilterio | 3 |
@StckPro | 2 |
@quantisnow | 2 |
@FlashAlert_me | 2 |
@Jarvis_Alerts | 1 |
![]() |
@Tradesense_me $ENTA ? ? Target Price $ENTA SVB Leerink analyst Roanna Ruiz maintains Enanta Pharma with a Market Perform and low… https://t.co/6jlMGYzpEF 3:01am |
![]() |
@newsfilterio $ENTA SVB Leerink analyst Roanna Ruiz maintains Enanta Pharma with a Market Perform and lowers the price target fro… https://t.co/hVaDphN8pl 3:01am |
![]() |
@Jarvis_Alerts $ENTA [Enanta Pharma]: SVB Leerink Maintains Market Perform Lowers Price Target $50 --> 49 Sign-up free for beta v… https://t.co/sgVstnMJYD January 27th 2023, 1:01pm |
![]() |
@StckPro $DE:9EP $ENTA NEW ARTICLE : SVB Securities Remains a Hold on Enanta Pharmaceuticals (ENTA) https://t.co/LbWVWPXbCD January 27th 2023, 12:01pm |
![]() |
@newsfilterio Form DEF 14A (other definitive proxy statements) filed with the SEC $ENTA https://t.co/Q8tD1pplrU January 21st 2023, 2:01am |
![]() |
@newsfilterio Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $ENTA https://t.co/fxfOeWbC7k January 21st 2023, 2:01am |
![]() |
@quantisnow $ENTA ? SEC Form DEFA14A filed by Enanta Pharmaceuticals Inc. https://t.co/HbDoSN8MoV 45 seconds delayed. January 20th 2023, 9:01pm |
![]() |
@FlashAlert_me $ENTA [15s. delayed] filed form DEFA14A on January 20, 16:05:00 https://t.co/XdCPQX7ma2 January 20th 2023, 9:01pm |
![]() |
@FlashAlert_me $ENTA [15s. delayed] filed form DEF 14A on January 20, 16:02:57 https://t.co/PlyTLksALu January 20th 2023, 9:01pm |
![]() |
@quantisnow $ENTA ? SEC Form DEF 14A filed by Enanta Pharmaceuticals Inc. https://t.co/eyNoMZ3xzL 45 seconds delayed. January 20th 2023, 9:01pm |
![]() |
@BiotechObserver How will $ENTA run a trial for its covid antiviral when there are no hospitalizations to prevent anymore? January 20th 2023, 3:01pm |
![]() |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 619 January 20th 2023, 12:01pm |
![]() |
@StckPro $Blurbs $ENTA NEW ARTICLE : SVB Securities Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA)… https://t.co/s0PNETkJWX January 16th 2023, 5:01am |
![]() |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 688 January 13th 2023, 8:01pm |
![]() |
@PMDiChristina $ENTA swinging https://t.co/CvWgjwooj7 January 13th 2023, 3:01am |
![]() |
@APKeyton RT @DewDiligence: @avidresearch $ENTA's EDP-235 may actually be able to prevent COVID transmission. EDP-235 prevents animal-to-animal trans… January 12th 2023, 2:01am |
![]() |
@FLHedgie @DewDiligence @avidresearch Given $ENTA’s history, they may be in Phase 3 by 2035. ? January 11th 2023, 6:01pm |
![]() |
@StckPro $Blurbs $ENTA NEW ARTICLE : Enanta Pharmaceuticals (ENTA) Gets a Buy from JMP Securities https://t.co/1FTIaxoTo0 Ge… https://t.co/tYE5DC39MW January 11th 2023, 6:01pm |
![]() |
@DewDiligence @avidresearch $ENTA's EDP-235 may actually be able to prevent COVID transmission. EDP-235 prevents animal-to-animal… https://t.co/i8l9EkTVIk January 11th 2023, 6:01pm |
![]() |
@FlashAlert_me $ENTA [15s. delayed] filed SEC form 4: Treasurer and CFO MELLETT PAUL J: Converted securities 2,812 of Common Stoc… https://t.co/3pFz7FHD6k January 11th 2023, 12:01am |
![]() |
@DewDiligence Bullish for $ENTA's EDP-235? $SRNE's SARS-CoV-2 PI has some safety questions in ph1b dataset: https://t.co/cWUwb0e3sk January 9th 2023, 5:01pm |
![]() |
@MarcJacksonLA $ENTA Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Outlook at the 41… https://t.co/7J7whfawla January 9th 2023, 3:01pm |
![]() |
@PMDiChristina $ENTA nice swing https://t.co/FuAhCefH4n January 9th 2023, 2:01am |
![]() |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 295 January 8th 2023, 3:01pm |
![]() |
@Tickeron $ENTA in Downtrend: its price may drop because broke its higher Bollinger Band on January 6, 2023. View odds for th… https://t.co/N8ZvJV0Of6 January 8th 2023, 3:01pm |
![]() |
@Tickeron $ENTA's Aroon indicator reaches into Uptrend on January 3, 2023. View odds for this and other indicators:… https://t.co/mCSBaQc6C1 January 7th 2023, 8:01pm |
![]() |
@Tickeron $ENTA's Aroon indicator reaches into Uptrend on January 3, 2023. View odds for this and other indicators:… https://t.co/FjeB1uKc9M January 7th 2023, 2:01am |
![]() |
@StckPro $Blurbs $ENTA NEW ARTICLE : Enanta Pharmaceuticals (ENTA) Gets a Hold from RBC Capital https://t.co/i7YUQJE35F Get… https://t.co/hx7GpbxKAZ January 7th 2023, 1:01am |
![]() |
@DewDiligence Key additions/changes in $ENTA's corporate slide set: https://t.co/Ziwowi48m2 January 6th 2023, 8:01pm |
![]() |
@StckPro $Blurbs $ENTA NEW ARTICLE : JMP Securities Sticks to Its Buy Rating for Enanta Pharmaceuticals (ENTA)… https://t.co/Apx263EHwN January 6th 2023, 8:01pm |
![]() |
@DewDiligence $ENTA's updated corporate slide set (1/6/23): https://t.co/8sPIGjouhW January 6th 2023, 5:01pm |
![]() |
@DewDiligence Brief notes on what $ENTA will be presenting at JPM: https://t.co/FjrT8Wv3Em January 6th 2023, 3:01pm |
![]() |
@Briefingcom $ENTA: Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Outlook at the... https://t.co/BBWf9yQBV2 January 6th 2023, 2:01pm |
![]() |
@StckPro $ENTA NEW ARTICLE : Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Out… https://t.co/bIBCYh1oP7 January 6th 2023, 12:01pm |
![]() |
@FlashAlert_me $ENTA [15s. delayed]: Issued Press Release on January 06, 07:00:00: Enanta Pharmaceuticals to Provide Updates on it… https://t.co/gOrR0b8L3N January 6th 2023, 12:01pm |
![]() |
@StockNewsBot2 $ENTA Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Outlook at the 41… https://t.co/45QCnj19Ve January 6th 2023, 12:01pm |
![]() |
@stock_titan $ENTA Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Outlook at the 41… https://t.co/nRvTvkxO2a January 6th 2023, 12:01pm |
![]() |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 354 January 3rd 2023, 4:01pm |
![]() |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 353 January 3rd 2023, 4:01pm |
![]() |
@otcdynamics $ENTA Enanta Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference https://t.co/aux9JsjoFk January 3rd 2023, 2:01pm |
![]() |
@newsfilterio Enanta Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference $ENTA https://t.co/3Dlvem9AIe January 3rd 2023, 12:01pm |
![]() |
@StckPro $ENTA NEW ARTICLE : Enanta Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference… https://t.co/xQv3StbunU January 3rd 2023, 12:01pm |
![]() |
@FlashAlert_me $ENTA [15s. delayed]: Issued Press Release on January 03, 07:00:00: Enanta Pharmaceuticals to Present at the 41st A… https://t.co/BmUWn95wXw January 3rd 2023, 12:01pm |
![]() |
@StockNewsBot2 $ENTA Enanta Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference https://t.co/plASKkyP1l January 3rd 2023, 12:01pm |
![]() |
@stock_titan $ENTA Enanta Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference https://t.co/fuRKlkKcf3 January 3rd 2023, 12:01pm |
![]() |
@SeekingAlpha $ENTA - Enanta: Deep Losses In FY 2022 Look To Be Justified Given Macro Landscape. https://t.co/pE4yjrp1vq #finance #markets #stockmarket December 30th 2022, 6:12pm |
![]() |
@PMDiChristina $ENTA bottom look https://t.co/hReX9ui5Fx December 30th 2022, 4:12am |
![]() |
@Scotty46028837 $enta Top analyst price target for stocks for the week. https://t.co/vYGKwqayUr December 22nd 2022, 6:12am |
![]() |
@Random13664585 $ENTA Top Analyst Ratings and Price Targets for this week... https://t.co/p2wkML3fhf December 21st 2022, 7:12pm |
![]() |
@Harry81835773 $ENTA Top analyst price target for next week:~ ?https://t.co/mE6fZt9KiL December 21st 2022, 2:12pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.